Converting enzyme-inhibition in diabetic nephropathy.
Mathiesen
E R
ER
Hvidøre Hospital, Klampenborg, Denmark.
Parving
H H
HH
Hommel
E
E
D000419:Albuminuria; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005665:Furosemide / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy; D008790:Metoprolol / Q000627:therapeutic use*; D011446:Prospective Studies
D006830:Hydralazine; D005665:Furosemide; D002216:Captopril; D008790:Metoprolol